CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,800 shares, a growth of 3,700.0% from the February 13th total of 100 shares. Based on an average daily trading volume, of 126,800 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

OTCMKTS CNBX opened at $0.01 on Friday. The company’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.01. CNBX Pharmaceuticals has a 52-week low of $0.01 and a 52-week high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.